Abbott anti-profiteering case stayed, hope for other firms

Experts say this could prompt firms to seek a stay on anti-profiteering proceedings till the time the issue surrounding constitutional validity is settled by high courts.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news